Oncopeptides AB (publ)
SSE:ONCO.ST
7.264 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 178.536 | 173.407 | 344.515 | 362.187 | 840.255 | 926.186 | 375.617 | 404.05 | 40.251 | 2.293 | 11.966 |
| Short Term Investments
| 0 | 0.032 | 0.348 | 2.112 | 12.227 | 0 | -0.85 | -0.262 | -0.262 | 0 | 0 |
| Cash and Short Term Investments
| 178.536 | 173.439 | 344.515 | 362.187 | 840.255 | 926.186 | 375.617 | 404.05 | 40.251 | 2.293 | 11.966 |
| Net Receivables
| 0 | 2.194 | 0 | 11.873 | 12.227 | 6.976 | 2.456 | 1.189 | 2.963 | 0 | 0.047 |
| Inventory
| 4.371 | 2.425 | 0 | 0 | 8.665 | 0 | -2.456 | 71.983 | -2.963 | 0 | 0 |
| Other Current Assets
| 0 | 24.842 | 18.497 | 36.201 | 33.652 | 44.702 | 14.871 | 73.171 | 11.056 | 1.938 | 0.932 |
| Total Current Assets
| 212.58 | 202.9 | 364.034 | 412.373 | 894.799 | 970.888 | 441.316 | 477.221 | 54.269 | 4.231 | 12.944 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 27.111 | 34.626 | 20.438 | 24.744 | 38.33 | 17.192 | 2.363 | 2.339 | 1.1 | 0.007 | 0.015 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 1.408 | 1.83 | 2.111 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 1.408 | 1.83 | 2.111 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0.851 | 0.851 | 3.622 | 1.035 | 0.851 | 0.263 | 0.263 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | -0.851 | 8.175 | 2.262 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 4.501 | 0.852 | 0 | -26.152 | 0 | 0 | 0 | -0.001 | 0 | 0.164 | 0.163 |
| Total Non-Current Assets
| 31.612 | 35.478 | 21.289 | 27.003 | 51.957 | 22.6 | 3.214 | 2.601 | 1.363 | 0.171 | 0.178 |
| Total Assets
| 244.192 | 238.378 | 385.323 | 439.376 | 946.756 | 993.488 | 444.53 | 479.822 | 55.633 | 4.402 | 13.123 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 18.171 | 15.025 | 28.219 | 35.702 | 136.135 | 80.986 | 25.27 | 15.681 | 8.016 | 5.115 | 2.568 |
| Short Term Debt
| 0 | 0 | 5.999 | -117.741 | -188.08 | -72.737 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0.579 | 6.778 | 7.025 | 14.24 | 5.478 | 4.056 | 0.954 | 0 | 0.186 | 0 |
| Deferred Revenue
| 0 | 0.5 | 0 | 128.681 | 197.46 | 77.353 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 33.184 | 28.829 | 44.676 | 42.894 | -5.861 | -5.289 | 84.514 | 43.358 | 21.28 | 1.701 | 2.949 |
| Total Current Liabilities
| 51.355 | 44.933 | 85.672 | 225.289 | 354.4 | 165.18 | 113.84 | 59.993 | 29.296 | 7.002 | 5.517 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 121.894 | 126.156 | 0 | 3.206 | 6.929 | 8.243 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 16.658 | 10.509 | 5.358 | 0.013 | 8.53 | 23.052 | 14.858 | 1.824 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 138.552 | 136.665 | 5.358 | 3.219 | 15.459 | 31.295 | 14.858 | 1.824 | 0 | 0 | 0 |
| Total Liabilities
| 189.907 | 181.598 | 91.03 | 228.508 | 369.859 | 196.475 | 128.698 | 61.817 | 29.296 | 7.002 | 5.517 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 2.297 | 0.918 | 1.542 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0 | 10.511 | 10.479 | 8.366 | 7.549 | 6.157 | 4.899 | 4.423 | 2.449 | 2.046 | 1.506 |
| Retained Earnings
| 0 | -5,365.987 | -5,116.414 | -4,778.463 | -3,348.146 | -1,753.452 | -961.919 | -542.462 | -294.85 | -180.405 | -127.064 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -2.297 | -0.918 | -1.542 | 0.002 | 0.022 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 54.285 | 5,412.256 | 5,402.525 | 4,981.883 | 3,919.036 | 2,544.306 | 1,272.83 | 956.044 | 318.738 | 175.759 | 133.163 |
| Total Shareholders Equity
| 54.285 | 56.78 | 294.293 | 210.868 | 576.897 | 797.013 | 315.832 | 418.005 | 26.337 | -2.6 | 7.606 |
| Total Equity
| 54.285 | 56.78 | 294.293 | 210.868 | 576.897 | 797.013 | 315.832 | 418.005 | 26.337 | -2.6 | 7.606 |
| Total Liabilities & Shareholders Equity
| 244.192 | 238.378 | 385.323 | 439.376 | 946.756 | 993.488 | 444.53 | 479.822 | 55.633 | 4.402 | 13.123 |